Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 13 von 61
Journal of oral pathology & medicine, 1999-03, Vol.28 (3), p.112-116
1999
Volltextzugriff (PDF)

Details

Autor(en) / Beteiligte
Titel
The in vitro post-antifungal effect of nystatin on Candida species of oral origin
Ist Teil von
  • Journal of oral pathology & medicine, 1999-03, Vol.28 (3), p.112-116
Ort / Verlag
Oxford, UK: Blackwell Publishing Ltd
Erscheinungsjahr
1999
Quelle
Wiley-Blackwell Journals
Beschreibungen/Notizen
  • ABSTRACT The post‐antifungal effect (PAFE) is defined as the suppression of growth that persists following limited exposure of yeasts to antimycotics and subsequent removal of the drug. Although limited data are available on the PAFE of nystatin on oral isolates of C. albicans, there is no information on non‐albicans Candida species. As nystatin is the commonest antifungal agent prescribed in dentistry, the main aim of this investigation was to measure the PAFE of oral isolates of Candida belonging to six different species (five isolates each of C. albicans, C. tropicalis, C. krusei, C. parapsilosis, C. glabrata and C. guilliermondii) following limited exposure (1 h) to nystatin. The yeasts were examined for the presence of the PAFE after 1 h exposure to the minimum inhibitory concentration (MIC) of nystatin. The PAFE was determined as the difference in time (h) required for the growth of the drug‐free control and the drug‐exposed test cultures to increase to the 0.05 absorbance level following removal of the antifungal agent. The mean duration of nystatin‐elicited PAFE was lowest for C. albicans (6.85 h) and greatest for C. parapsilosis (15.17 h), while C. krusei (11.58 h), C. tropicalis (12.73 h), C. glabrata (8.51 h), and C. guilliermondii (8.68 h) elicited intermediate values. These findings clarify another intriguing possibility for the persistent, chronic recurrence of oral C. albicans infections despite apparently adequate antifungal drug regimens. The significant variations in nystatin‐induced PAFE amongst non‐albicans species may also have clinical implications, in terms of nystatin regimens used in the management of these fungal infections.

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX